Selecta Biosciences Adds $15.1 Million

Selecta Biosciences Inc., a Watertown, Mass.-based biopharma company focused on the development of immunomodulatory nanoparticles, has raised $15.1 million in Series B funding. Return backers Polaris Venture Partners and Flagship Ventures were joined by NanoDimension and Timothy Springer. The company previously raised $2.3 million.

North AmericaUSBriefs